Table 1.
Readout | Change in Insulin Resistance | Direct/Indirect | Acute/Chronic | Notes |
---|---|---|---|---|
Activation of net hepatic glycogen synthesis | ↓ | Direct | Acute | Requires both hyperinsulinemia and hyperglycemia. |
Suppression of hepatic gluconeogenesis | ↓ | Indirect | Acute | Related to suppression of WAT lipolysis leading to decreased NEFA and glycerol turnover and hepatic acetyl-CoA content. There may also be a small direct effect of insulin by suppression of intrahepatic lipolysis. |
Suppression of hepatic glucose production | ↓ | Direct and indirect | Acute | Variable contributions of gluconeogenesis and glycogenolysis depending on species and fasting duration. |
INSR Tyr phosphorylation and IRK activity | ↓ | Direct | Acute | |
IRS Tyr phosphorylation | ↓ | Direct | Acute | |
AKT Ser/Thr phosphorylation | ↓ | Direct | Acute | Multiple inputs to Ser473 phosphorylation. |
Gluconeogenic gene expression | ↑ | Direct | Chronic | Especially G6pc, Pck1. |
De novo lipogenesis | ↓ | Direct | Chronic | Multiple inputs including mTORC1, ChREBP. |
Fasting plasma insulin | ↑ | Direct and indirect | Chronic | Crude surrogate of hepatic insulin resistance, useful in large epidemiologic studies. |
INSR, insulin receptor; IRK, INSR kinase; IRS, insulin receptor substrate; WAT, white adipose tissue; NEFA, nonesterified fatty acid.